Abstract:Objective To explore the value of fludeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET/CT) in the accurate localization and lateralization of brain epileptogenic focus. Methods From June 2011 to July 2013, 69 patients with medically intractable epilepsy from the General Hospital of Northern Theater Command were selected. 18F-FDG interictal PET/CT, magnetic resonance imaging (MRI), electroencephalo gram (EEG) were performed in those patients and the results were compared with the electroenephalogram monitoring during operations and the pathological tests. Results Among 69 cases of epileptic focus resection, accuracy rate of localization and lateralization of epileptogenic focus by interictal 18F-FDG PET/CT were 62.3% (43/69) and 78.3% (54/69) respectively. Among 43 case of PET/CT localization of simple temporal lobe lesions, the intraoperative electroencephalogram monitoring and surgical pathology confirmed the same localization in 36 cases and the same lateralization in 37 cases, with an accuracy rate of 83.7% (36/43) and an accuracy rate of 86.0% (37/43), which were higher than those in non-temporal lobe lesions [26.9% (7/26), 65.4% (17/26)], the differences were statistically significant (P < 0.05). The lateral accuracy [78.3% (54/69)] of PET/CT for brain epilepsy was significantly higher than that in the location [62.3% (43/69)], the difference was statistically significant (P < 0.05). Accuracy rate of localization of epileptogenic focus in 69 patients by MRI was 42.0% (29/69), accuracy rate of localization of epileptogenic focus in 69 patients by EEG were 44.9% (31/69). PET/CT had higher accuracy rate of localization than MRI and EEG (χ2 = 5.692, 4.196, all P < 0.05). Conclusion Interical 18F-FDG PET/CT possesses higher value than routine examinations such as MRI and EEG in the localization of epileptogenic focus, especially in temporal lobe localization focus.
[1] 潘博,马云川.PET在难治性癫痫中的应用价值与限度[J].中国临床医学影像杂志,2006,17(8):464-467.
[2] Sarikaya I. PET studies in epilepsy [J]. Am J Nucl Med Mol Imaging,2015,5(5):416-430.
[3] Morbelli S,Garibotto V,Van De Giessen E,et al. A Cochrane review on brain [18F] FDG PET in dementia:limitations and future perspectives [J]. Eur J Nucl Med Mol Imaging,2015,42(10):1487-1491.
[4] 王雪梅,赵世刚,王宏伟,等.PET/CT与脑电图和MRI对难治性癫痫的对比研究[J].中华临床医师杂志,2010,4(8):1213-1217.
[5] Kumar A,Chugani HT. The role of radionuclide imaging in epilepsy,Part 1:Sporadic temporal and extratemporal lobe epilepsy [J]. J Nucl Med,2013,54(10):1775-1781.
[6] Peter J,Houshmand S,Warner TJ,et al. Applications of global quantitative 18F-FDG-PET analysis in temporal lobe epilepsy [J]. Nucl Med Commun,2016,37(3): 223-230.
[7] 申强,李建红,王荣福.PET-MRI新技术应用进展[J].中国医学装备,2017,14(4):7-12.
[8] Lai V,Mak HK,Yung AW,et al. Neuroimaging techniques in epilepsy [J].Hong Kong Med J,2010,16(4):292-298.
[9] 赵春雷,陈自谦,钱根年,等.18F-FDG PET脑显像在难治性颞叶癫痫定侧诊断中的价值研究[J].临床放射学杂志,2016,35(7):1004-1007.
[10] 林耀云,林志国,李勇.18F-FDG PET/CT显像对颞叶癫痫灶定位的价值[J].中国临床神经外科杂志,2013,18(2):65-67.
[11] 邵明岩,吴晓牧,徐荣.PET-CT、MRI及EEG对发作间期难治性癫痫患者致痫灶定位的研究[J].南昌大学学报:医学版,2014,54(9):33-37.
[12] 闫秀鹏,王海祥,周文静,等.基于高频颅内脑电的致痫区定位和网络分析[J].北京生物医学工程,2017,36(3):229-236.
[13] Chandra PS,Vaghania G,Bal CS,et al. Role of concordance between ictal-subtracted SPECT and PET in predicting long-term outcomes after epilepsy surgery [J]. Epilepsy Res,2014,108(10):1782-1789.
[14] Kim YK,Lee DS,Lee SK,et al. 18F-FDG PET in localization of frontal lobe epilepsy:comparison of visual and SPM analysis [J]. J Nucl Med,2002,43(9):1167-1174.
[15] Kumar A,Chugani HT. The Role of Radionuclide Imaging in Epilepsy,Part 1:Sporadic Temporal and Extratemporal Lobe Epilepsy [J]. J Nucl Med Technol,2017,45(1):14-21.
[16] Haneef Z,Chen DK. Functional neuro-imaging as a pre-surgical tool in epilepsy [J]. Ann Indian Acad Neuro,2014, 17(1):S56-S64.
[17] 陆东燕,高硕,杨卫东,等.发作间期18F-FDG联合13N-NH3·H2O PET脑显像在颞叶内侧癫痫术前定位中的价值[J].中国临床医学影像杂志,2010,21(8):533-535,552.
[18] 郝科技,王荣福.PET-MR在脑神经系统疾病中的应用现状及展望[J].中国医学装备,2017,14(4):13-17.
[19] Duncan JS,Winston GP,Koepp MJ,et al. Brain imaging in the assessment for epilepsy surgery [J]. Lancet Neurol,2016,15(4):420-433.